Prostatic Neoplasms  >>  IMF-001  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IMF-001 / ImmunoFrontier
NCT01234012: Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1

Completed
1
23
US
IMF-001
ImmunoFrontier, Inc.
Solid Tumor
11/13
03/14

Download Options